FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2155492053> ?p ?o ?g. }

• W2155492053 endingPage "1305" @default.
• W2155492053 startingPage "1301" @default.
• W2155492053 abstract "Objective: To report and discuss a case of rhabdomyolysis in an elderly patient with neuropathic pain who was treated with gabapentin. Case Summary: An 85-year-old diabetic woman was hospitalized for severe pain in her lower limbs and difficulty in walking, compromising her daily activities. On admission, the woman's laboratory parameters, including creatine kinase (CK) and myoglobin, were in the normal range. Neurologic evaluation suggested a diagnosis of diabetic neuropathic pain, and therapy with gabapentin 150 mg 3 times daily was started. On the same day, the patient developed psychomotor agitation and gastric pain, which were treated with haloperidol 10 mg and lansoprazole 30 mg, respectively. In the following hours, the severity of muscular pain increased and the patient developed myopathy with acute renal failure (CK 459 U/L, myoglobin 11 437 ng/mL, creatinine 4.59 mg/dL), which worsened progressively during the next 2 days (CK 3095 U/L, myoglobin 17 000 mg/dL, creatinine 4.77 mg/dL) despite discontinuation of haloperidol and lansoprazole. No signs of trauma or edema, suggesting possible compartmental or crush syndrome, were detected. Gabapentin was then withdrawn and the patient's condition rapidly improved. Complete recovery followed in about 10 days. Discussion: Severe myopathy is an unexpected adverse reaction to gabapentin therapy. In this patient, a possible contribution of haloperidol or lansoprazole to the adverse event cannot be excluded. However, worsening of the clinical picture despite discontinuation of these drugs, together with rapid improvement observed after withdrawal of gabapentin, strongly suggest a causative role of gabapentin. According to the Naranjo probability scale, gabapentin was the probable cause of myopathy in this patient. The mechanism by which gabapentin may induce myopathy is unknown. The early onset of the syndrome after initiation of treatment with gabapentin in therapeutic doses is compatible with the picture of an idiosyncratic adverse response. Conclusions: Pathogenetic and clinical investigations are required to explore what mechanisms account for gabapentin-related muscular alterations at the time of onset, including electromyographic recordings as well as muscle and nerve histopathologic examinations. Until more information is available, clinicians should consider the possibility of discontinuing gabapentin treatment in patients showing muscular pain and signs of myopathy." @default.
• W2155492053 created "2016-06-24" @default.
• W2155492053 creator A5017900514 @default.
• W2155492053 creator A5058374861 @default.
• W2155492053 creator A5068616704 @default.
• W2155492053 creator A5068794344 @default.
• W2155492053 creator A5077498316 @default.
• W2155492053 creator A5079187407 @default.
• W2155492053 date "2007-07-01" @default.
• W2155492053 modified "2023-10-18" @default.
• W2155492053 title "Gabapentin-Induced Severe Myopathy" @default.
• W2155492053 cites W1975097351 @default.
• W2155492053 cites W1988370123 @default.
• W2155492053 cites W2015048672 @default.
• W2155492053 cites W2026291721 @default.
• W2155492053 cites W2030805274 @default.
• W2155492053 cites W2036924982 @default.
• W2155492053 cites W2062334785 @default.
• W2155492053 cites W2067978628 @default.
• W2155492053 cites W2078529090 @default.
• W2155492053 cites W2079300365 @default.
• W2155492053 cites W2092478517 @default.
• W2155492053 cites W2096669975 @default.
• W2155492053 cites W2098797772 @default.
• W2155492053 cites W2136738995 @default.
• W2155492053 cites W2153640035 @default.
• W2155492053 cites W2398029547 @default.
• W2155492053 cites W4249457808 @default.
• W2155492053 cites W4254013587 @default.
• W2155492053 doi "https://doi.org/10.1345/aph.1k077" @default.
• W2155492053 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17565043" @default.
• W2155492053 hasPublicationYear "2007" @default.
• W2155492053 type Work @default.
• W2155492053 sameAs 2155492053 @default.
• W2155492053 citedByCount "26" @default.
• W2155492053 countsByYear W21554920532012 @default.
• W2155492053 countsByYear W21554920532013 @default.
• W2155492053 countsByYear W21554920532015 @default.
• W2155492053 countsByYear W21554920532016 @default.
• W2155492053 countsByYear W21554920532017 @default.
• W2155492053 countsByYear W21554920532019 @default.
• W2155492053 countsByYear W21554920532020 @default.
• W2155492053 countsByYear W21554920532021 @default.
• W2155492053 countsByYear W21554920532022 @default.
• W2155492053 countsByYear W21554920532023 @default.
• W2155492053 crossrefType "journal-article" @default.
• W2155492053 hasAuthorship W2155492053A5017900514 @default.
• W2155492053 hasAuthorship W2155492053A5058374861 @default.
• W2155492053 hasAuthorship W2155492053A5068616704 @default.
• W2155492053 hasAuthorship W2155492053A5068794344 @default.
• W2155492053 hasAuthorship W2155492053A5077498316 @default.
• W2155492053 hasAuthorship W2155492053A5079187407 @default.
• W2155492053 hasConcept C126322002 @default.
• W2155492053 hasConcept C142724271 @default.
• W2155492053 hasConcept C197934379 @default.
• W2155492053 hasConcept C204787440 @default.
• W2155492053 hasConcept C2776608144 @default.
• W2155492053 hasConcept C2777107010 @default.
• W2155492053 hasConcept C2777300911 @default.
• W2155492053 hasConcept C2778616394 @default.
• W2155492053 hasConcept C2778715236 @default.
• W2155492053 hasConcept C2779379848 @default.
• W2155492053 hasConcept C2780948584 @default.
• W2155492053 hasConcept C36880943 @default.
• W2155492053 hasConcept C42219234 @default.
• W2155492053 hasConcept C513476851 @default.
• W2155492053 hasConcept C71924100 @default.
• W2155492053 hasConceptScore W2155492053C126322002 @default.
• W2155492053 hasConceptScore W2155492053C142724271 @default.
• W2155492053 hasConceptScore W2155492053C197934379 @default.
• W2155492053 hasConceptScore W2155492053C204787440 @default.
• W2155492053 hasConceptScore W2155492053C2776608144 @default.
• W2155492053 hasConceptScore W2155492053C2777107010 @default.
• W2155492053 hasConceptScore W2155492053C2777300911 @default.
• W2155492053 hasConceptScore W2155492053C2778616394 @default.
• W2155492053 hasConceptScore W2155492053C2778715236 @default.
• W2155492053 hasConceptScore W2155492053C2779379848 @default.
• W2155492053 hasConceptScore W2155492053C2780948584 @default.
• W2155492053 hasConceptScore W2155492053C36880943 @default.
• W2155492053 hasConceptScore W2155492053C42219234 @default.
• W2155492053 hasConceptScore W2155492053C513476851 @default.
• W2155492053 hasConceptScore W2155492053C71924100 @default.
• W2155492053 hasIssue "7-8" @default.
• W2155492053 hasLocation W21554920531 @default.
• W2155492053 hasLocation W21554920532 @default.
• W2155492053 hasOpenAccess W2155492053 @default.
• W2155492053 hasPrimaryLocation W21554920531 @default.
• W2155492053 hasRelatedWork W1962920716 @default.
• W2155492053 hasRelatedWork W2012467229 @default.
• W2155492053 hasRelatedWork W2051160165 @default.
• W2155492053 hasRelatedWork W2057542355 @default.
• W2155492053 hasRelatedWork W2155492053 @default.
• W2155492053 hasRelatedWork W2416821331 @default.
• W2155492053 hasRelatedWork W2799644646 @default.
• W2155492053 hasRelatedWork W3105970077 @default.
• W2155492053 hasRelatedWork W3197918108 @default.
• W2155492053 hasRelatedWork W4322496153 @default.
• W2155492053 hasVolume "41" @default.

• next